Cargando…

Ticagrelor Does Not Inhibit Adenosine Transport at Relevant Concentrations: A Randomized Cross-Over Study in Healthy Subjects In Vivo

BACKGROUND AND PURPOSE: In patients with myocardial infarction, ticagrelor reduces cardiovascular and sepsis-related mortality, and can cause dyspnea. It is suggested that this is caused by adenosine receptor stimulation, because in preclinical studies, ticagrelor blocks the nucleoside transporter a...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Berg, T. N. A., El Messaoudi, S., Rongen, G. A., van den Broek, P. H. H., Bilos, A., Donders, A. R. T., Gomes, M. E., Riksen, N. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624811/ https://www.ncbi.nlm.nih.gov/pubmed/26509673 http://dx.doi.org/10.1371/journal.pone.0137560

Ejemplares similares

The Effect of Eplerenone on Adenosine Formation in Humans In Vivo: A Double-Blinded Randomised Controlled Study
por: van den Berg, T. N. A., et al.
Publicado: (2014)

Plasma levels of the cardiovascular protective endogenous nucleoside adenosine are reduced in patients with primary aldosteronism without affecting ischaemia‐reperfusion injury: A prospective case‐control study
por: van den Berg, T. N. A. (Daniëlle), et al.
Publicado: (2019)

The effect of dipyridamole on the pharmacokinetics of metformin: a randomized crossover study in healthy volunteers
por: El Messaoudi, S., et al.
Publicado: (2016)

Impact of Metformin on Endothelial Ischemia-Reperfusion Injury in Humans In Vivo: A Prospective Randomized Open, Blinded-Endpoint Study
por: El Messaoudi, Saloua, et al.
Publicado: (2014)

Cost-effectiveness of clopidogrel vs. ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome
por: van den Broek, Wout W A, et al.
Publicado: (2022)

Circulating adenosine increases during human experimental endotoxemia but blockade of its receptor does not influence the immune response and subsequent organ injury
por: Ramakers, Bart P, et al.
Publicado: (2011)

Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function
por: Teng, Renli, et al.
Publicado: (2018)

Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis
por: Alsharif, Khalaf F., et al.
Publicado: (2015)

Factors associated with hyperresponsiveness to adenosine 5’‐monophosphate in healthy subjects
por: Cox, Claire Alette, et al.
Publicado: (2019)

Adenosine increases during human experimental endotoxemia, but does not influence the immune response and subsequent organ injury
por: Ramakers, B, et al.
Publicado: (2010)

Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study
por: Azzahhafi, Jaouad, et al.
Publicado: (2022)

Metformin improves survival in intensive care unit patients, but why?
por: Riksen, Niels P, et al.
Publicado: (2013)

A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration
por: Li, Xiaoye, et al.
Publicado: (2018)

Reference intervals for plasma, urinary, and salivary concentrations of free metanephrines in dogs: Relevance to the diagnosis of pheochromocytoma
por: van den Berg, Marit F., et al.
Publicado: (2023)

Unraveling the pharmacokinetic interaction of ticagrelor and MEDI2452 (Ticagrelor antidote) by mathematical modeling
por: Almquist, J, et al.
Publicado: (2016)

Ticagrelor Prevents Endothelial Cell Apoptosis through the Adenosine Signalling Pathway in the Early Stages of Hypoxia
por: Feliu, Catherine, et al.
Publicado: (2020)

Intracerebral microdialysis of adenosine and adenosine monophosphate – a systematic review and meta‐regression analysis of baseline concentrations
por: van der Mierden, Stevie, et al.
Publicado: (2018)

Dipyridamole modulates the innate immune response during human endotoxemia
por: Ramakers, B, et al.
Publicado: (2011)

Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?
por: Giraud, Eline L., et al.
Publicado: (2023)

Clinical Relevance of Genetic Analysis in Patients With Pituitary Adenomas: A Systematic Review
por: van den Broek, Medard F. M., et al.
Publicado: (2019)

Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of Treatment
por: Bergmeijer, Thomas O., et al.
Publicado: (2018)

Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects
por: de Graaf, Dennis M., et al.
Publicado: (2020)

Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial
por: Li, Pan, et al.
Publicado: (2016)

Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects
por: Teng, Renli, et al.
Publicado: (2017)

Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety
por: Dobesh, Paul P, et al.
Publicado: (2014)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

Ticagrelor Associated Heart Block: The Need for Close and Continued Monitoring
por: Sharma, Munish, et al.
Publicado: (2017)

Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study
por: Bours, Martijn JL, et al.
Publicado: (2007)

Subjectively Reported Symptoms in Patients with Persistent Atrial Fibrillation and Emotional Distress
por: Kupper, Nina, et al.
Publicado: (2013)

Ranges of phenotypic flexibility in healthy subjects
por: van den Broek, T. J., et al.
Publicado: (2017)

Highly selective detection of methanol over ethanol by a handheld gas sensor
por: van den Broek, J., et al.
Publicado: (2019)

Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial
por: Johnson, Thomas W., et al.
Publicado: (2020)

Metabolism of ticagrelor in patients with acute coronary syndromes
por: Adamski, Piotr, et al.
Publicado: (2018)

Specific Investigation of Sample Handling Effects on Protease Activities and Absolute Serum Concentrations of Various Putative Peptidome Cancer Biomarkers
por: van den Broek, Irene, et al.
Publicado: (2010)

Dipyridamole augments the antiinflammatory response during human endotoxemia
por: Ramakers, Bart P, et al.
Publicado: (2011)

Bioequivalence assessment of two Ticagrelor formulations under fasting condition in healthy Pakistani subjects
por: Hashmi, Naghma, et al.
Publicado: (2023)

Southern Saskatchewan Ticagrelor Registry experience
por: Dehghani, Payam, et al.
Publicado: (2014)

Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A(2A) receptor levels in rats subjected to neuroinflammation
por: Smith, Mark D, et al.
Publicado: (2014)

Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel
por: Gasecka, Aleksandra, et al.
Publicado: (2020)

Ischaemic Preconditioning and Postconditioning do not Affect Adenosine A(1) and A(2A) Receptor Sensitivity
por: Riksen, Niels P., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3cglfqe2b5jkfddrj1hn6ltlmo